Abstract
Purpose
Repair of hernia typically makes use of a prosthetic material; synthetic or biologic in nature. Any material which enters the body is subject to interrogation by the inflammation and immune system in addition to numerous other cell families, the outcome of which ultimately determines the success of the repair. In this review, we discuss the fundamental biology which occurs in situ when a biomaterial associates with a tissue, compare and contrast the techniques available to predict this in vitro, and review how features of hernia repair materials specifically may manipulate tissue interrogation and integration. Finally, we conclude our article by examining how biocompatibility impacts surgical practise and how a better understanding of the manner by which materials and tissues interact could benefit hernia repair.
Materials and methods
A review of the literature was conducted using appropriate scientific search engines in addition to inclusion of findings from the groups’ primary research.
Results
Using pre-clinical assays to anticipate the biocompatibility of a medical device is critical; however, to maximise the scientific power of in vitro findings, we must carefully consider the in vivo niche of the cells with which we are working. Excessive in vitro culture or contact to non-self materials can add compounding complexity to studies involving leucocytes for instance; therefore, we must ensure careful and stringent assay design when developing techniques for assaying pre-clinical biocompatibility. Furthermore, many of the features associated with hernia repair material design specifically, included to enhance their mechanical or biodegradation characteristics, are inadvertently instructive to cells, and therefore, throughout the prototype stages of a materials development, regular biocompatibility assessment must be performed.
Conclusion
The biocompatibility of a material is rate limiting in its ability to function as a medical device. The future of hernia repair materials will rely on close cohesion between the surgical and scientific communities to ensure the most robust biocompatibility assessment techniques, and models are utilised to predict the efficacy of a given material in a particular surgical application.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29:2941–2953
Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ (1997) Mechanisms of tissue repair from wound healing to fibrosis. Int J Biochem Cell Biol 29:5–17
ten Raa S, van der Tol P, Sluiter W, Hofland LJ, van Eijck CHJ, Jeekel H (2006) The role of neutrophils and oxygen free radicals in post-operative adhesions. J Surg Res 136:45–52
Butterfield TA, Best TM, Merrick MA (2006) The dual role of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train 41:457–465
Anderson JM, Miller KM (1984) Biomaterial biocompatibility and the macrophage. Biomaterials 5:5–10
Kirkpatrick CJ, Krump-Konvalinkova V, Unger RE, Bittinger F, Otto M, Peters K (2002) Tissue response and biomaterial integration: the efficacy of in vitro methods. Biomol Eng 19:211–217
Daubay DA, Franz MG (2003) Acute wound healing: the biology of acute wound failure. Surg Clin North Am 83:463–481
Hunt JA, Vince DG, Williams DF (1993) Image analysis in the evaluation of biomaterials. J Biomed Eng 15:39–45
Bryan N, Ashwin H, Bayon Y, Wohlert S, Smart N, Hunt J (2012) The innate oxygen dependent immune pathway is a sensitive parameter to predict the performance of biological graft materials. Biomaterials 33:6380–6392
Bryan N, Ashwin H, Bayon Y, Wohlert S, Smart N, Hunt JA (2012) In vitro activation and degranulation of human acute inflammatory cells in response to direct contact with synthetic hernia repair meshes. Clin Biochem 45:672–676
Bryan N, Andrews KD, Hunt JA (2011) Elucidating the contribution of the elemental composition of fetal calf serum towards antigenic expression of primary human umbilical vein endothelial cells in vitro. Biosci Rep 31:199–210
Bryan N, Ashwin H, Bayon Y, Wohlert S, Smart N, Hunt JA (2012) Reactive oxygen species (ROS); a family of fate deciding molecules pivotal in successful wound healing. ECM 24:249–265
Bryan N, Birch P, Bond D, Stanley C, Hunt J (2012) Examination of the effect of acoustic force capture on the ultra purification of leukocyte subpopulations translatable throughout a variety research and diagnostic applications. J Tissue Eng Regen Med. doi:10.1002/term.1474
Smart N, Bryan N, Hunt JA (2012) A scientific evidence for the efficacy of biologic implants for soft tissue reconstruction. Colorectal Dis 14:1–6
Khang D, Choi J, Im YM, Kim YJ, Jang JH, Kang SS, Nam TH, Song J, Park JW (2012) Role of subnano-, nano- and micron-surface features on osteoblast differentiation of bone marrow mesenchymal stem cells. Biomaterials 33:5997–6007
Hamer-Hodges DW, Scott NB (1985) Surgeon’s workshop: replacement of an abdominal wall defect using expanded PTFE sheet (GORE-TEX). J Royal Coll Surg Edin 30:65–67
Cevasco M, Itani KM (2012) Ventral hernia repair with synthetic, composite and biologic mesh: characteristics, indications and infection profile. Surg Infect 13:209–215
Le D, Deveney CW, Reaven NL, Funk SE, McGaughey KJ, Martindale RG (2012) Mesh choice in ventral hernia: so many choices, so little time. Am J Surg 205:602–607
Muysoms FE, Miserez M, Berrevoet F, Camanelli G, Champault GG, Chelala E, Dietz UA, Eker HH, El Nakadi I, Hauters P, Hidalgo Pascual M, Hoeferlin A, Klinge U, Montgomery A, Simmermacher RKJ, Simons MP, Smietanski M, Sommeling C, Tollens T, Vierendeels T, Kingsnorth A (2009) Classification of primary and incisional abdominal wall hernias. Hernia 13:407–414
Kanters AE, Krpata DM, Blatnik JA, Novitsky YM, Rosen MJ (2012) Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs. J Am Coll Surg 215:787–793
Kissane N, Itani KMF (2012) A decade of ventral incisional hernia repairs with biologic acellular dermal matrix: what have we learned? Plast Reconstr Surg 130:194S–202S
Rosen MJ, Krpata DM, Ermlich B, Blatnik J (2013) A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilising biologic mesh. Ann Surg 257:991–996
Slater NJ, van der Kolk Hendriks T, van Goor H, Bleichrodt RP (2013) Biologic grafts for ventral hernia repair: a systematic review. Am J Surg 205:220–230
Muysoms F, Campanelli G, Champault GG, DeBeaux AC, Dietz UA, Jeekel J, Klinge U, Kockerling F, Mandala V, Montgomery A, Morales Conde S, Puppe F, Simmermacher RKJ, Smietanski M, Miserez M (2012) EuraHS: the development of an international online platform for registration and outcome measurement of ventral abdominal wall hernia repair. Hernia 16:239–250
Hood K, Millikan K, Pittman T, Zelhart M, Secemsky B, Rajan M, Myers J, Luu M (2013) Abdominal wall reconstruction: a case series of ventral hernia repair using the component separation technique with biologic mesh. Am J Surg 205:322–328
Bochiccio GV, De Castro GP, Bochiccio KM, Weeks J, Rodriguez E, Scalea TM (2013) Comparison study of acellular dermal matrices in complicated hernia surgery. J Am Coll Surg 217:606–613
Muysoms FE, Deerenberg EB, Peeters E, Agresta F, Berrevoet F, Campanelli G, Ceelen W, Champault GG, Corcione F, Cuccurullo D, DeBeaux AC, Dietz UA, Fitzgibbons RJ, Gillon JF, Hilgers RD, Jeekel J, Kyle-Leinhase I, Kockerling F, Mandala V, Montgomery A, Morales-Conde S, Simmermacher RKJ, Schumpelick V, Smietanski M, Walgenbach M, Miserez M (2013) Recommendations for reporting outcomes in abdominal wall repair. Hernia 17:423–433
Itani KMF, Rosen M, Vargo D, Awad S, DeNoto G, Butler CE and the RICH study group (2012) Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH study. Surgery 152:498–505
Belyansky I, Heniford T (2012) Discussion: a decade of ventral incisional hernia repairs with biologic acellular dermal matrix: what have we learned? Plast Reconstruct Surg 130:203S–205S
Bryan N. Ashwin H, Bayon Y, Wohlert S, Smart N, Hunt JA (2013) Evaluation of the in vivo performance of tissue-based biomaterials in a rat full thickness abdominal wall model. JBMR. doi:10.1002/jbm.b.33050. [Epub ahead of print]
Halm JA, de Wall LL, Steyerberg EW, Jeekel J, Lange LW (2007) Intraperitoneal polyproylene mesh repair complicates subsequent abdominal surgery. World J Surg 31:423–431
Gray SH, Vick CC, Graham LA, Finan KR, Neumayer LA, Hawn MT (2008) Risk of complications from enterotomy or unplanned bowel resection during elective hernia repair. Arch Surg 143(6):582–586
Conflict of interest
NB declares conflict of interest not directly related to the submitted work.
CB declares no conflict of interest.
NJS declares conflict of interest not directly related to the submitted work.
JH declares conflict of interest not directly related to the submitted work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bryan, N., Battersby, C., Smart, N. et al. A review of biocompatibility in hernia repair; considerations in vitro and in vivo for selecting the most appropriate repair material. Hernia 19, 169–178 (2015). https://doi.org/10.1007/s10029-014-1307-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10029-014-1307-8